What Factors Propelled The Growth Of The Retinal Disorder Treatment Market In The Past?
The retinal disorder treatment market has seen considerable growth due to a variety of factors.
•The market size of treatments for retinal disorders has seen substantial growth lately. From $12.59 billion in 2024, it is expected to expand to $13.82 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.7%.
Several factors have contributed to this growth during the historical period, such as the innovation of anti-VEGF therapies, an aging global population, a rise in the occurrence of retinal disorders, advancements in diagnostic tools enabling earlier detection, growing public awareness and screening programs, as well as wider accessibility to health care services.
What Is The Projected Growth And Market Size For The Retinal Disorder Treatment Sector?
The retinal disorder treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of retinal disorder treatment is predicted to witness substantial growth in the years to come. The development rate is estimated to reach $19.62 billion by 2029, developing at a compound annual growth rate (CAGR) of 9.2%.
This projected growth during the forecast period can be linked to patient-focused strategies in retina-related health services, escalating global healthcare spending, increased attention to combination therapies for retina diseases, emerging trends of home-based monitoring for retinal disorders, the rising usage of implantable devices for eye treatment, and the adoption of regenerative medicine for retinal disease treatment. The forthcoming trends include advancements in ophthalmic imaging technologies, the evolution of less invasive surgical techniques, the incorporation of artificial intelligence in diagnostics, the progress of drug delivery technologies, the inclusion of virtual reality in rehabilitating the retina, alliances between research institutions and pharmaceutical firms and the development of gene therapies for genetic retinal disorders.
Which Factors Are Boosting Growth In The Retinal Disorder Treatment Market?
The escalating prevalence of retinal diseases is anticipated to fuel the expansion of the retinal disorder treatment market. Medical conditions that impact the light-sensitive tissue at the back of the eye, known as the retina, and lead to severe vision impairment or complete vision loss, are all referred to as retinal diseases. Solutions such as laser therapy, vitrectomy, and retinal implants are provided by retinal disorder treatments to help manage and decrease the symptoms of retinal disorders. For example, it was estimated in January 2023 by the International Agency for the Prevention of Blindness, an international alliance based in the UK, that age-related macular degeneration (AMD) would account for about 5% of worldwide blindness. Moreover, age-related macular degeneration diseases are forecasted to affect 288 million people by 2040. As a result, the escalating prevalence of retinal diseases is spurring the expansion of the retinal disorder treatment market.
What Key Areas Define The Segmentation Of The Global Retinal Disorder Treatment Market?
The retinal disorder treatment market covered in this report is segmented –
1) By Type: Macular Degeneration, Diabetic Retinopathy, Other Types
2) By Dosage Form: Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Macular Degeneration: Dry Macular Degeneration, Wet Macular Degeneration
2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
3) By Other Types: Retinal Detachment, Retinitis Pigmentosa, Uveitis, Other Retinal Disorders
Pre-Book The Retinal Disorder Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Retinal Disorder Treatment Market?
An evident trend in the retinal disorder treatment market is the rise in product innovations. In order to maintain their market dominance, major corporations are releasing novel products. A pertinent example of this is the January 2022 approval received by F. Hoffmann-La Roche AG, a pharmaceutical entity based in Switzerland, from the U.S. Food and Drug Administration (FDA) for their bispecific antibody product, Vabysmo. This product, used in the treatment of neovascular or wet age-related macular degeneration (AMD) and diabetic macular edema (DME), is the first of its kind - an injectable eye medication that disrupts two disease pathways linked to vision-imparing retinal diseases, namely angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Clinical trials have demonstrated this medication's ability to offer equivalent vision enhancements when juxtaposed with conventional therapy, and it carries a solid safety profile. This approval heralds a significant advancement in the therapy for retinal disorders, promising patients improved vision and a less burdensome treatment routine.
Who Are the Key Players in the Retinal Disorder Treatment Market?
Major companies operating in the retinal disorder treatment market include:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Takeda Pharmaceutical Company Limited
• Regeneron Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Genentech Inc.
• Santen Pharmaceutical Co. Ltd.
• Apellis Pharmaceuticals Inc.
• Kubota Pharmaceutical Holdings Co. Ltd
• Alimera Sciences Inc.
• Ocular Therapeutix Inc.
• EyePoint Pharmaceuticals Inc.
• Adverum Biotechnologies Inc.
• Kodiak Sciences Inc.
• Acucela Inc.
• IVERIC bio Inc.
• Oxurion NV
• Graybug Vision Inc.
• Icon Bioscience Inc.
• Clearside Biomedical Inc.
• Aerpio Pharmaceuticals Inc.
• Neurotech Pharmaceuticals Inc.
• Ophthotech Corporation
• Opthea Limited
• PanOptica Inc.
• ThromboGenics NV
What Is The Most Dominant Region In The Retinal Disorder Treatment Market?
North America was the largest region in the retinal disorder treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
